The GSAS Harvard Biotechnology Club is a student organization that hosts events and provides services that allow members to explore the world of business and biotechnology. The Biotech Club's mission is to bridge the gap between industry and academia by building relationships with companies operating in the biotechnology and healthcare sphere.
Corporate sponsorships support all club activities and operations.
HGWISE and Harvard Biotech Club Biotech Panel
HGWISE and the Harvard Biotech Club present: A perspective on women’s careers in biotechnology and pharma
Cliona Molony, PhD - Head of Computational Biomedicine, Pfizer
Melissa Naylor, MD, PhD - Research Statistician, Pfizer
Katie Williams, PhD - Senior Scientist, Applied BioMath
Ho-Chou Tu, PhD - Scientist, Alnylam Pharmaceuticals
Rebecca Canter, PhD - Postdoctoral Scientist, Biogen
WHEN: *Monday, April 3, 6 - 7 PM*
WHERE: *TMEC 227*, Harvard Medical School, Boston MA 02215
Please RSVP here: https://goo.gl/forms/KorXD6ikC5hf5is13
The Emerging Technology Portal: An Information Session with RA Capital
Do you have an idea or technology you are interested in commercializing? Have you ever considered starting a life science company? Join the Harvard Biotech Club for a discussion with Joel Batson, Scientific Project Coordinator at RA Capital Management. RA Capital is a crossover investment manager dedicated to evidence-based investing in public and private healthcare and life science companies. Joel is spearheading a new program called “the Portal”, an adaptive due diligence questionnaire allowing innovators to apply for funding and business planning assistance from RA Capital’s experienced investment team. RA Capital is currently seeking volunteers to beta test the Portal, based on a proposed idea or actual drug development program. Please see the attached FAQ sheet and attend the information session to learn more about RA Capital and how you can participate in the testing phase for the Portal.
When: April 10, 2017 from 5-6 PM
Where: TMEC 227, Harvard Medical School
Opportunities in Industry, featuring Evelo Biosciences
Join the Harvard Biotech Club and representatives from Evelo Biosciences for a discussion about career paths and opportunities in industry.
Evelo Biosciences is a biotech company founded in 2015 that focuses on developing therapies for autoimmune disease and cancer based on deciphering the immuno-microbiome. They are a rapidly growing company with over $40M raised in funding, and they're actively recruiting, especially for a summer internship program centered on scientific strategy and corporate development (see attached flyer for more details). Presentation topics will include career paths, R&D at Evelo, internship opportunities, and current open positions, followed by a Q&A session.
Brian Goodman, Cofounder, Head of Scientific Strategy
Leslie Wardwell Scott, Director of Business Development
Hank Wu, Head of Computational Biology and Bioinformatics
WHEN: Thursday, April 13 5-6PM
WHERE: TMEC 227, Harvard Medical School
Please RSVP here: https://goo.gl/forms/wLVhoZSNt4klaQw83
Pizza will be provided!